Sponsor Dossier
Asteri Pharma
Sponsor Dossier for Asteri Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: INCRELEX
- Brand: METOPIRONE
- Brand: TEGLUTIK
About
Asteri Pharma is an Australian Private Company with ABN 69665948158, registered in Victoria. The entity is Active.
Portfolio
Asteri Pharma holds 3 brands on the ARTG, all of which are indexable. All 3 brands have Product Information on file. 2 brands are PBS-listed and 2 brands have PBAC outcomes on record. 1 brand has an AusPAR on record. Notable brands include INCRELEX, METOPIRONE, and TEGLUTIK.
Therapeutic focus —
Oncology: 1 brand — Endocrinology: 1 brand — Neurology: 1 brand
PBS footprint
2 brands in the portfolio are PBS-listed, with the latest PBS schedule date touched on 2026-05-01.
Regulatory activity
The latest PBAC outcome dates to 2022-03-01, with 2 brands holding PBAC outcomes on record. The latest AusPAR dates to 2019-11-19, with 1 brand holding an AusPAR on record.